ABBOTT LABORATORIES (ABT) FY2026 Q1 P&L / Income Statement
2026-01-01 to 2026-03-31
Revenue by Business Segment
2026-01-01 to 2026-03-31
Swipe to see the full flow
Chart details
ABBOTT LABORATORIES (ABT) FY2026 Q1 P&L / Income Statement
Income statement for 2026-01-01 through 2026-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Net sales
- 11,164,000,000 US dollars
- Cost of products sold, excluding amortization of intangible assets
- 4,890,000,000 US dollars
- Gross profit (calculated)
- 6,274,000,000 US dollars
- Operating expenses (calculated)
- 4,929,000,000 US dollars
- Operating earnings
- 1,345,000,000 US dollars
- Other income (expense), net (calculated)
- 104,000,000 US dollars
- Earnings before taxes
- 1,449,000,000 US dollars
- Taxes on earnings
- 372,000,000 US dollars
- Net Earnings
- 1,077,000,000 US dollars
- Established Pharmaceuticals
- 1,426,000,000 US dollars
- Nutritional Products
- 2,017,000,000 US dollars
- Diagnostic Products
- 2,180,000,000 US dollars
- Medical Devices
- 5,539,000,000 US dollars
- Amortization of intangible assets
- 422,000,000 US dollars
- Research and development
- 767,000,000 US dollars
- Selling, general, and administrative
- 3,740,000,000 US dollars
- Revenue before reconciliation (calculated)
- 11,162,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- Other
- 2,000,000 US dollars. Reported reconciliation to consolidated revenue.
- Established Pharmaceuticals costs (calculated)
- 1,061,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Nutritional Products costs (calculated)
- 1,706,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Diagnostic Products costs (calculated)
- 1,845,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Medical Devices costs (calculated)
- 3,646,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Reconciling items (calculated)
- 1,561,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
56.2%
Gross profit / revenue
Operating margin
12.0%
Operating profit / revenue
Cash conversion
122.1%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
